BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 23787193)

  • 1. Predictive value of transforming growth factor-β1in Chagas disease: towards a biomarker surrogate of clinical outcome.
    Saraiva RM; Waghabi MC; Vilela MF; Madeira FS; Sperandio da Silva GM; Xavier SS; Feige JJ; Hasslocher-Moreno AM; Araujo-Jorge TC
    Trans R Soc Trop Med Hyg; 2013 Aug; 107(8):518-25. PubMed ID: 23787193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of transforming growth factor-β1 and tumour necrosis factor levels with left ventricular function in Chagas disease.
    Curvo EO; Ferreira RR; Madeira FS; Alves GF; Chambela MC; Mendes VG; Sangenis LHC; Waghabi MC; Saraiva RM
    Mem Inst Oswaldo Cruz; 2018 Feb; 113(4):e170440. PubMed ID: 29513876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implication of transforming growth factor-beta1 in Chagas disease myocardiopathy.
    Araújo-Jorge TC; Waghabi MC; Hasslocher-Moreno AM; Xavier SS; Higuchi Mde L; Keramidas M; Bailly S; Feige JJ
    J Infect Dis; 2002 Dec; 186(12):1823-8. PubMed ID: 12447769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid ameliorates early cardiac dysfunction after coronary microembolization and suppresses TGF-β1/Smad3 and CTGF expression.
    Chen Z; Qian J; Ma J; Chang S; Yun H; Jin H; Sun A; Zou Y; Ge J
    Int J Cardiol; 2013 Sep; 167(5):2278-84. PubMed ID: 22727959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left atrial volume provides independent prognostic value in patients with Chagas cardiomyopathy.
    Nunes MC; Barbosa MM; Ribeiro AL; Colosimo EA; Rocha MO
    J Am Soc Echocardiogr; 2009 Jan; 22(1):82-8. PubMed ID: 19131007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism.
    Papadopoulou E; Anagnostopoulos K; Tripsianis G; Tentes I; Kakolyris S; Galazios G; Sivridis E; Simopoulos K; Kortsaris A
    Neoplasma; 2008; 55(3):229-38. PubMed ID: 18348656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of serum transforming growth factor-β1 in lung cancer.
    Hou YL; Chen H; Dong ZH; Xue CJ; Wu YF; Luo HX; Wu YC; Li CH
    Cancer Epidemiol; 2013 Oct; 37(5):750-3. PubMed ID: 23727122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum transforming growth factor-beta1 and epidermal growth factor in biliary atresia.
    Vejchapipat P; Theamboonlers A; Poomsawat S; Chittmittrapap S; Poovorawan Y
    Eur J Pediatr Surg; 2008 Dec; 18(6):415-8. PubMed ID: 19012231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of QT interval parameters for mortality risk stratification in Chagas' disease: results of a long-term follow-up study.
    Salles G; Xavier S; Sousa A; Hasslocher-Moreno A; Cardoso C
    Circulation; 2003 Jul; 108(3):305-12. PubMed ID: 12835217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.
    De Jaeger K; Seppenwoolde Y; Kampinga HH; Boersma LJ; Belderbos JS; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1378-87. PubMed ID: 15050313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of all-cause mortality in chronic Chagas' heart disease in the current era of heart failure therapy.
    Theodoropoulos TA; Bestetti RB; Otaviano AP; Cordeiro JA; Rodrigues VC; Silva AC
    Int J Cardiol; 2008 Aug; 128(1):22-9. PubMed ID: 18258318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas' heart disease.
    Freitas HF; Chizzola PR; Paes AT; Lima AC; Mansur AJ
    Int J Cardiol; 2005 Jul; 102(2):239-47. PubMed ID: 15982491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer.
    Kattan MW; Shariat SF; Andrews B; Zhu K; Canto E; Matsumoto K; Muramoto M; Scardino PT; Ohori M; Wheeler TM; Slawin KM
    J Clin Oncol; 2003 Oct; 21(19):3573-9. PubMed ID: 12913106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum level of transforming growth factor-beta1 (TGF-beta1) and the expression of TGF-beta receptor type II in peripheral blood mononuclear cells in patients with autoimmune hepatitis.
    Sakaguchi K; Kitano M; Nishimura M; Senoh T; Ohta T; Terao M; Shinji N; Koide N; Tsuji T
    Hepatogastroenterology; 2004; 51(60):1780-3. PubMed ID: 15532825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [C-reactive protein and interleukin-6 serum levels increase as Chagas disease progresses towards cardiac failure].
    López L; Arai K; Giménez E; Jiménez M; Pascuzo C; Rodríguez-Bonfante C; Bonfante-Cabarcas R
    Rev Esp Cardiol; 2006 Jan; 59(1):50-6. PubMed ID: 16434004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early postoperative plasma transforming growth factor-beta1 is a strong predictor of biochemical progression after radical prostatectomy.
    Shariat SF; Walz J; Roehrborn CG; Montorsi F; Jeldres C; Saad F; Karakiewicz PI
    J Urol; 2008 Apr; 179(4):1593-7. PubMed ID: 18295256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma.
    Dong ZZ; Yao DF; Yao M; Qiu LW; Zong L; Wu W; Wu XH; Yao DB; Meng XY
    Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):288-95. PubMed ID: 18522884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischemic cerebrovascular events in patients with Chagas cardiomyopathy: a prospective follow-up study.
    Nunes MC; Barbosa MM; Ribeiro AL; Barbosa FB; Rocha MO
    J Neurol Sci; 2009 Mar; 278(1-2):96-101. PubMed ID: 19162278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in chagas' heart disease.
    Martinelli M; de Siqueira SF; Sternick EB; Rassi A; Costa R; Ramires JA; Kalil Filho R
    Am J Cardiol; 2012 Oct; 110(7):1040-5. PubMed ID: 22727179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β1-selective adrenoceptor antagonists increase plasma levels of anti-p2β antibodies and decrease cardiac involvement in chronic progressive Chagas heart disease.
    Vicco MH; Pujato N; Bontempi I; Rodeles L; Marcipar I; Bottasso OA
    Can J Cardiol; 2014 Mar; 30(3):332-7. PubMed ID: 24370375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.